tradingkey.logo
tradingkey.logo
Search

Arcutis Biotherapeutics Inc

ARQT
Add to Watchlist
25.960USD
+0.580+2.29%
Close 09-21 16:00ET
3.26BMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

+2.29%

5 Days

+6.96%

1 Month

+3.51%

6 Months

+16.88%

Year to Date

-10.61%

1 Year

+49.37%

Key Figures

25.570Open
26.080High
253.52KVolume
LossP/E TTM
18.42P/E Dynamic
--Dividend TTM
0.20%Turnover Ratio
25.380Prev. Close
25.190Low
6.49MTurnover
LossP/E Static
14.79P/B
0.00%Div Yield TTM
-0.59%ROA
31.77052wk High
13.87Volume Ratio
-140.04MNet Profit
125.59MShares
-0.0153EPS TTM
1.53Beta
-1.43%ROE
16.57052wk Low
3.49%Amplitude
91.58%Gross Margin
3.26BMarket Cap
-1.59Reward/Risk
3.61%Risk Rate
More news coming soon, stay tuned...

Arcutis Biotherapeutics Inc's Score

-0.14vs previous score
Forecast8.25
Financial Health8.33
Technical3.95
Valuation Dimensions6.43
Institutional Confidence10.00
Risk Assessment6.34

Media Coverage

Coverage Level

Very Low
Very High
Neutral

Analyst Rating

Strong Buy
Buy
Hold
Sell
Strong Sell
BuyCurrent Rating
37.000Target Price
+45.78%Upside Space
Current Rating2026-092026-082026-072026-062026-052026-042026-032026-02
Strong Buy22222222
Buy55555555
Hold11111111
Sell00000000
Strong Sell00000000

Arcutis Biotherapeutics Inc Technical Analysis

1m
5m
15m
30m
1h
2h
4h
D
W
M
1m
5m
15m
D

Technical Indicators

Buy

Summary

Buy

Moving Average

Strong buy

Financial Indicators

Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Earnings

Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
0.11/0.04
Revenue / Forecast
129.86M/118.85M

Arcutis Biotherapeutics Inc Profile

SectorPharmaceuticals
Ticker SymbolARQT
Number of employees342
CountryUnited States of America

Ownership

ShareholdersProportion
Suvretta Capital Management, LLC9.56%
Frazier Life Sciences Management, L.P.7.89%
Rubric Capital Management LP6.61%
BlackRock Institutional Trust Company, N.A.6.38%
Shareholder TypesProportion
Investment Advisor33.25%
Investment Advisor/Hedge Fund30.69%
Hedge Fund25.66%
Private Equity8.06%

FAQs

What is the current price of Arcutis Biotherapeutics Inc (ARQT)?

The current price of Arcutis Biotherapeutics Inc (ARQT) is 25.96.

What is the symbol of Arcutis Biotherapeutics Inc?

The ticker symbol of Arcutis Biotherapeutics Inc is ARQT.

What is the 52-week high of Arcutis Biotherapeutics Inc?

The 52-week high of Arcutis Biotherapeutics Inc is 31.77.

What is the 52-week low of Arcutis Biotherapeutics Inc?

The 52-week low of Arcutis Biotherapeutics Inc is 16.57.

What is the market capitalization of Arcutis Biotherapeutics Inc?

The market capitalization of Arcutis Biotherapeutics Inc is 3.26B.

Is Arcutis Biotherapeutics Inc (ARQT) currently rated as Buy, Hold, or Sell?

According to analysts, Arcutis Biotherapeutics Inc (ARQT) has an overall rating of Buy, with a price target of 37.00.

What is the Earnings Per Share (EPS TTM) of Arcutis Biotherapeutics Inc (ARQT)?

The Earnings Per Share (EPS TTM) of Arcutis Biotherapeutics Inc (ARQT) is -0.02.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.